These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 19736814)

  • 1. [Guidelines in RA treatment: concepts on safety and recommendations using anti-TNF-alpha inhibitors. Grupo de Estudio de Nuevas Terapias de Enfermedades reumáticas (GENTE)].
    Díaz-Jouanen E; Abud-Mendoza C; Garza-Elizondo MA; Medrano-Ramírez G; Burgos-Vargas R; Orozco-Alcalá JJ; Pacheco-Tena CF; Pineda C; Pozos-Espíndola JC; Ramos-Niembro F; Robles-San-Román M; Santana-Sahagún JE;
    Rev Invest Clin; 2009; 61(3):252-66. PubMed ID: 19736814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can tumor necrosis factor inhibitors be safely used in pregnancy?
    Ali YM; Kuriya B; Orozco C; Cush JJ; Keystone EC
    J Rheumatol; 2010 Jan; 37(1):9-17. PubMed ID: 20008917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor therapy and the risk of serious infection and malignancy in patients with early rheumatoid arthritis: a meta-analysis of randomized controlled trials.
    Thompson AE; Rieder SW; Pope JE
    Arthritis Rheum; 2011 Jun; 63(6):1479-85. PubMed ID: 21360522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug insight: Anti-tumor necrosis factor therapy for inflammatory arthropathies during reproduction, pregnancy and lactation.
    Skomsvoll JF; Wallenius M; Koksvik HS; Rødevand E; Salvesen KA; Spigset O; Kvien TK
    Nat Clin Pract Rheumatol; 2007 Mar; 3(3):156-64. PubMed ID: 17334338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNFalpha-blocking agents or conventional immunosuppressive drugs in the therapy of children with uveitis? - an evidence based approach.
    Winterhalter S; Niehues T
    Klin Padiatr; 2008; 220(6):342-7. PubMed ID: 18949668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists.
    Askling J; Fored CM; Brandt L; Baecklund E; Bertilsson L; Feltelius N; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; Klareskog L
    Ann Rheum Dis; 2005 Oct; 64(10):1421-6. PubMed ID: 15829572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rheumatoid arthritis and reproduction.
    Golding A; Haque UJ; Giles JT
    Rheum Dis Clin North Am; 2007 May; 33(2):319-43, vi-vii. PubMed ID: 17499710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events.
    Leombruno JP; Einarson TR; Keystone EC
    Ann Rheum Dis; 2009 Jul; 68(7):1136-45. PubMed ID: 18753157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs.
    Avouac J; Allanore Y
    Expert Opin Pharmacother; 2008 May; 9(7):1121-8. PubMed ID: 18422470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Medical treatment of juvenile idiopathic arthritis].
    Horneff G; Augustin S
    Med Monatsschr Pharm; 2008 Sep; 31(9):326-36; quiz 337-8. PubMed ID: 18831464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignancy and biologic therapy in rheumatoid arthritis.
    Askling J; Bongartz T
    Curr Opin Rheumatol; 2008 May; 20(3):334-9. PubMed ID: 18388527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF-alpha antagonism and cancer risk in rheumatoid arthritis: is continued vigilance warranted?
    Park HJ; Ranganathan P
    Discov Med; 2012 Mar; 13(70):229-34. PubMed ID: 22463799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register.
    Askling J; Baecklund E; Granath F; Geborek P; Fored M; Backlin C; Bertilsson L; Cöster L; Jacobsson LT; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; van Vollenhoven R; Klareskog L; Feltelius N
    Ann Rheum Dis; 2009 May; 68(5):648-53. PubMed ID: 18467516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of patients with rheumatoid arthritis in Latin America: a consensus position paper from Pan-American League of Associations of Rheumatology and Grupo Latino Americano De Estudio De Artritis Reumatoide.
    Massardo L; Suárez-Almazor ME; Cardiel MH; Nava A; Levy RA; Laurindo I; Soriano ER; Acevedo-Vázquez E; Millán A; Pineda-Villaseñor C; Galarza-Maldonado C; Caballero-Uribe CV; Espinosa-Morales R; Pons-Estel BA
    J Clin Rheumatol; 2009 Jun; 15(4):203-10. PubMed ID: 19502907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unresolved issue: should patients with RA and a history of malignancy receive anti-TNF therapy?
    Brar A; Hiebert T; El-Gabalawy H
    Nat Clin Pract Rheumatol; 2007 Mar; 3(3):120-1. PubMed ID: 17334334
    [No Abstract]   [Full Text] [Related]  

  • 16. TNF antagonist safety in rheumatoid arthritis: updated evidence from observational registries.
    Nasir A; Greenberg JD
    Bull NYU Hosp Jt Dis; 2007; 65(3):178-81. PubMed ID: 17922666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A safety assessment of tumor necrosis factor antagonists during pregnancy.
    Osting VC; Carter JD
    Expert Opin Drug Saf; 2010 May; 9(3):421-9. PubMed ID: 20367495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular safety of anti-TNF-alpha therapies: facts and unsettled issues.
    Cacciapaglia F; Navarini L; Menna P; Salvatorelli E; Minotti G; Afeltra A
    Autoimmun Rev; 2011 Aug; 10(10):631-5. PubMed ID: 21539939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy.
    Rosner I; Haddad A; Boulman N; Feld J; Avshovich N; Slobodin G; Rozenbaum M
    Rheumatology (Oxford); 2007 Sep; 46(9):1508; author reply 1508-9. PubMed ID: 17684027
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular morbidity and mortality in patients with rheumatoid arthritis: vascular alterations and possible clinical implications.
    Pieringer H; Pichler M
    QJM; 2011 Jan; 104(1):13-26. PubMed ID: 21068083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.